PhRMA Clinical Trial Principles Restate Proprietary Rights To Protocols
Executive Summary
The Pharmaceutical Research & Manufacturers of America is committing its members to "timely communication of meaningful results of controlled clinical trials" without respect to the outcome
You may also be interested in...
Clinical Trial Publication Can Be Stalled By Outside Forces, PhRMA Says
Timely disclosure of clinical trial results is not always within the control of the sponsoring drug company, the Pharmaceutical Research & Manufacturers of America says in revised 1guidelines for industry
Clinical Trial Publication Can Be Stalled By Outside Forces, PhRMA Says
Timely disclosure of clinical trial results is not always within the control of the sponsoring drug company, the Pharmaceutical Research & Manufacturers of America says in revised 1guidelines for industry
ClinicalTrials.Gov Registry Needs Legislative Boost, JAMA Editorial Says
Congress needs to add funding and enforcement tools to the legislation creating the ClinicalTrials.gov clinical trials registry, a "special communication" in the July 23/30 issue of the Journal of the American Medical Association says